Julie Izzo

5.1k total citations
57 papers, 2.9k citations indexed

About

Julie Izzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Julie Izzo has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Julie Izzo's work include Esophageal Cancer Research and Treatment (14 papers), Gastric Cancer Management and Outcomes (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Julie Izzo is often cited by papers focused on Esophageal Cancer Research and Treatment (14 papers), Gastric Cancer Management and Outcomes (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Julie Izzo collaborates with scholars based in United States, France and Netherlands. Julie Izzo's co-authors include Jaffer A. Ajani, K. S. Clifford Chao, Walter N. Hittelman, Jennifer Sims‐Mourtada, Xifeng Wu, Tsung‐Teh Wu, Ignacio I. Wistuba, Stephen G. Swisher, Adel K. El‐Naggar and Jie Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Julie Izzo

57 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Izzo United States 31 1.5k 1.3k 738 680 565 57 2.9k
Hiroyuki Hamakawa Japan 32 1.3k 0.9× 1.4k 1.0× 476 0.6× 439 0.6× 542 1.0× 145 3.0k
Ryo Miyahara Japan 35 1.1k 0.8× 1.5k 1.1× 646 0.9× 1.4k 2.0× 591 1.0× 101 3.3k
Fulvio Lonardo United States 32 1.3k 0.9× 1.4k 1.1× 341 0.5× 1.4k 2.1× 457 0.8× 79 3.4k
Torahiko Nakashima Japan 28 890 0.6× 1.2k 0.9× 1000 1.4× 414 0.6× 300 0.5× 140 3.0k
Shiu‐Feng Huang Taiwan 29 1.4k 0.9× 1.2k 0.9× 327 0.4× 944 1.4× 596 1.1× 78 2.9k
Hsuan-Ying Huang Taiwan 30 1.2k 0.8× 700 0.5× 429 0.6× 822 1.2× 434 0.8× 55 2.4k
Mu-Yan Cai China 33 1.7k 1.2× 735 0.5× 471 0.6× 473 0.7× 965 1.7× 58 2.9k
Hiroaki Ueo Japan 31 1.2k 0.8× 1.0k 0.8× 678 0.9× 581 0.9× 839 1.5× 133 2.9k
Kenneth K. Iwata United States 27 1.9k 1.3× 1.8k 1.3× 174 0.2× 976 1.4× 520 0.9× 50 3.4k
Takushi Monden Japan 28 1.1k 0.7× 1.1k 0.8× 686 0.9× 537 0.8× 309 0.5× 146 2.6k

Countries citing papers authored by Julie Izzo

Since Specialization
Citations

This map shows the geographic impact of Julie Izzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Izzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Izzo more than expected).

Fields of papers citing papers by Julie Izzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Izzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Izzo. The network helps show where Julie Izzo may publish in the future.

Co-authorship network of co-authors of Julie Izzo

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Izzo. A scholar is included among the top collaborators of Julie Izzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Izzo. Julie Izzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shien, Kazuhiko, Vassiliki A. Papadimitrakopoulou, Carmen Behrens, et al.. (2017). JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 16(10). 2234–2245. 84 indexed citations
2.
Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2016). Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients. Clinical Cancer Research. 22(24). 6278–6289. 103 indexed citations
3.
Riquelme, Erick, Carmen Behrens, Heather Lin, et al.. (2015). Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Research. 76(3). 675–685. 85 indexed citations
4.
Ileana, Ecaterina, Ignacio I. Wistuba, & Julie Izzo. (2015). From Uniplex to Multiplex Molecular Profiling in Advanced Non–Small Cell Lung Carcinoma. The Cancer Journal. 21(5). 413–424. 3 indexed citations
5.
Spivak-Kroizman, Taly R., Galen Hostetter, Richard G. Posner, et al.. (2013). Hypoxia Triggers Hedgehog-Mediated Tumor–Stromal Interactions in Pancreatic Cancer. Cancer Research. 73(11). 3235–3247. 163 indexed citations
6.
7.
Kim, Soo Mi, Eun Sung Park, Y. Choi, et al.. (2010). Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome. PLoS ONE. 5(11). e15074–e15074. 115 indexed citations
8.
Papadimitrakopoulou, Vassiliki A., Julie Izzo, Diane D. Liu, et al.. (2009). Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients. Cancer Prevention Research. 2(1). 14–21. 32 indexed citations
9.
Xing, Jinliang, Jaffer A. Ajani, Meng Chen, et al.. (2009). Constitutive Short Telomere Length of Chromosome 17p and 12q but not 11q and 2p Is Associated with an Increased Risk for Esophageal Cancer. Cancer Prevention Research. 2(5). 459–465. 63 indexed citations
10.
Pan, Jennifer, Jie Lin, Julie Izzo, et al.. (2009). Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 30(5). 785–792. 71 indexed citations
11.
Yen, Chia-Jui, Julie Izzo, Dung‐Fang Lee, et al.. (2008). Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma. Cancer Research. 68(8). 2632–2640. 49 indexed citations
12.
Izzo, Julie, Xifeng Wu, T. T. Wu, et al.. (2008). Therapy-induced expression of NF-κB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Diseases of the Esophagus. 22(2). 127–132. 14 indexed citations
13.
Chen, Yu-Jen, Jennifer Sims‐Mourtada, Julie Izzo, & K. S. Clifford Chao. (2007). Targeting the Hedgehog Pathway to Mitigate Treatment Resistance. Cell Cycle. 6(15). 1826–1830. 26 indexed citations
14.
Patel, Pooja, Paul F. Mansfield, Christopher H. Crane, et al.. (2007). Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer. 110(5). 989–995. 14 indexed citations
15.
Wislez, Marie, Nobukazu Fujimoto, Julie Izzo, et al.. (2006). High Expression of Ligands for Chemokine Receptor CXCR2 in Alveolar Epithelial Neoplasia Induced by Oncogenic Kras. Cancer Research. 66(8). 4198–4207. 130 indexed citations
16.
Wislez, Marie, Loreto Spencer, Julie Izzo, et al.. (2005). Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras. Cancer Research. 65(8). 3226–3235. 128 indexed citations
17.
Malhotra, Usha, Walter N. Hittelman, Tsung Teh Wu, et al.. (2005). Association of activated NF-kB, altered cyclin D1 and poor outcome in esophageal adenocarcinoma. Cancer Research. 65. 548–548. 1 indexed citations
18.
Izzo, Julie, Vali A. Papadimitrakopoulou, Heladio P. Ibarguen, et al.. (1998). Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 17(18). 2313–2322. 105 indexed citations
19.
Cvitkovic, Esteban & Julie Izzo. (1992). The Current and Future Place of Vinorelbine in Cancer Therapy. Drugs. 44(Supplement 4). 36–45. 41 indexed citations
20.
Recondo, Gonzálo, Thierry Guillot, C. Domenge, et al.. (1990). A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer. Cancer. 66(4). 640–644. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Hamakawa Breakdown of academic impact, for papers by Ryo Miyahara Breakdown of academic impact, for papers by Fulvio Lonardo Breakdown of academic impact, for papers by Torahiko Nakashima Breakdown of academic impact, for papers by Shiu‐Feng Huang Breakdown of academic impact, for papers by Hsuan-Ying Huang Breakdown of academic impact, for papers by Mu-Yan Cai Breakdown of academic impact, for papers by Hiroaki Ueo Breakdown of academic impact, for papers by Kenneth K. Iwata Breakdown of academic impact, for papers by Takushi Monden
Rankless by CCL
2026